Evidence map›Paper›PMID 24753420›Full record

ArticleNucleic acids research2014

Mechanistic insight into ligand binding to G-quadruplex DNA.

Francesco Saverio Di Leva, Ettore Novellino, Andrea Cavalli, Michele Parrinello, Vittorio Limongelli

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. ACS medicinal chemistry letters · 2018
    Article
  16. Article
  17. Article
  18. High-resolution three-dimensional NMR structure of theThe Journal of biological chemistry · 2017
    Article
  19. Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Francesco Saverio Di LevaDepartment of Drug Discovery and Development, Istituto Italiano di Tecnologia, via Morego, 30, I-16163 Genoa, Italy.
Ettore NovellinoDepartment of Pharmacy, University of Naples "Federico II", via D. Montesano, 49, I-80131 Naples, Italy.
Andrea CavalliDepartment of Drug Discovery and Development, Istituto Italiano di Tecnologia, via Morego, 30, I-16163 Genoa, Italy Department of Pharmacy and Biotechnology, Alma Mater Studiorum, University of Bologna, via Belmeloro, 6, I-40126 Bologna, Italy.
Michele ParrinelloDepartment of Chemistry and Applied Biosciences, ETH Zurich, and Facoltà di Informatica, Istituto di Scienze Computazionali, Università della Svizzera Italiana, via G. Buffi, 13, CH-6900 Lugano, Switzerland.
Vittorio LimongelliDepartment of Pharmacy, University of Naples "Federico II", via D. Montesano, 49, I-80131 Naples, Italy vittoriolimongelli@gmail.com.
University of Naples Federico II · ITETH Zurich · CHItalian Institute of Technology · ITUniversity of Bologna · IT

Funding

European Research Council 247075
6 · The paper itself

Abstract

Specific guanine-rich regions in human genome can form higher-order DNA structures called G-quadruplexes, which regulate many relevant biological processes. For instance, the formation of G-quadruplex at telomeres can alter cellular functions, inducing apoptosis. Thus, developing small molecules that are able to bind and stabilize the telomeric G-quadruplexes represents an attractive strategy for antitumor therapy. An example is 3-(benzo[d]thiazol-2-yl)-7-hydroxy-8-((4-(2-hydroxyethyl)piperazin-1-yl)methyl)-2H-chromen-2-one (compound 1: ), recently identified as potent ligand of the G-quadruplex [d(TGGGGT)]4 with promising in vitro antitumor activity. The experimental observations are suggestive of a complex binding mechanism that, despite efforts, has defied full characterization. Here, we provide through metadynamics simulations a comprehensive understanding of the binding mechanism of 1: to the G-quadruplex [d(TGGGGT)]4. In our calculations, the ligand explores all the available binding sites on the DNA structure and the free-energy landscape of the whole binding process is computed. We have thus disclosed a peculiar hopping binding mechanism whereas 1: is able to bind both to the groove and to the 3' end of the G-quadruplex. Our results fully explain the available experimental data, rendering our approach of great value for further ligand/DNA studies.

Indexed as

Molecular Docking SimulationBenzopyransBenzothiazolesBinding SitesDNAG-QuadruplexesHumansLigandsMolecular Dynamics SimulationThermodynamicsBenzopyransBenzothiazolesDNALigands

Identifiers

PMID24753420
PMCPMC4027208
OpenAlexW2157970694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.